Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by westcoast1000on Feb 10, 2023 11:30am
196 Views
Post# 35279727

RE:The only supporters of this stock are us Longs!

RE:The only supporters of this stock are us Longs!Les Alpes

Along those lines, the longer the situation streches out with no news, the better for the longs in my view.

That is because I accept the reasoning that we are in a news blackout, given the lack of anything from the company since Dec, 8 or so.

I also think that this process will NECESSARILY take a long time. We are unlikely to get a substantial offer without competitive bidding, and the BOD cannot be convinced they have the best possible offer without competitive bidding. That means both Roche and Pfizer, as weill as others, need to have all avaialble data and proceed internally within their own management to make an offer. Then ONCY has to compare them.

But who knows? I do believe they are negotiating. Following my further speculation, longer is better for us. I do not think we will hear anything until perhaps mid May, three months hence. 
<< Previous
Bullboard Posts
Next >>